However, it should be noted that the enrolled studies reporting MIR31HG expression in lung cancers consisted of LUAD and NSCLC, while the cancer types in TCGA were LUAD and LUSC, which may lead to potential difference in predictive value of MIR31HG on clinical outcomes between this meta-analysis and TCGA dataset. This evidence concerns the gene MIR31HG and lung carcinoma.